Screener
Ocular Therapeutix OCUL CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Operating lease liabilities | 1,768 | (256) |
| Net cash used in operating activities | (65,993) | (44,671) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (4,662) | (1,933) |
| Net cash used in investing activities | (4,662) | (1,933) |
| Cash flows from financing activities: | ||
| Proceeds from exercise of stock options | 294 | 4,183 |
| Net cash provided by financing activities | 294 | 4,183 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's capex?
- Ocular Therapeutix (OCUL) reported capex of $4.66M in Q1 2026.
- How has Ocular Therapeutix's capex changed year-over-year?
- Ocular Therapeutix's capex increased by 141.2% year-over-year, from $1.93M to $4.66M.
- What is the long-term trend for Ocular Therapeutix's capex?
- Over 4 years (2021 to 2025), Ocular Therapeutix's capex has grown at a 78.1% compound annual growth rate (CAGR), from $1.19M to $12.01M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Ocular Therapeutix's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude